By clicking CONTINUE, you agree that you are 18 years or older and agree to the Novartis Pharmaceuticals Corporations (NPC)
and to contact you for opinions regarding products, programs, and services. You understand that unless you unsubscribe by calling 1-888-669-6682 or clicking unsubscribe in a promotional email, your consent will remain valid.
Xiidra Savings Program
Terms & Conditions:
Limitations apply. Valid for patients with private (commercial) insurance only. The Xiidra Co-pay Card Program includes the Co-pay Card and rebate.
Eligible, commercially insured patients using the Co-pay Card pay $0 for their first prescription of Xiidra.
$0 first fill available for prescriptions up to 90 days. After the first fill, eligible, commercially insured patients may
pay as little as $0 for prescriptions of Xiidra, subject to a maximum monthly savings of $250 for each 30-day prescription
and $750 for each 90-day prescription. Patient is responsible for any costs once monthly savings limit is reached.
Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program,
(ii) where patient is not using insurance coverage at all, or (iii) where the patient's insurance plan reimburses for
the entire cost of the drug. The value of this program is exclusively for the benefit of patients and is intended to be
credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles.
Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from
other parties, including any health insurance program or plan, flexible spending account, or health care savings account.
Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use
of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance.
Program may not be combined with any third party rebate, coupon, or offer. Proof of purchase may be required.
Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.